Atulya Aman Khosla

6.2k total citations
52 papers, 221 citations indexed

About

Atulya Aman Khosla is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Genetics. According to data from OpenAlex, Atulya Aman Khosla has authored 52 papers receiving a total of 221 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 15 papers in Oncology and 10 papers in Genetics. Recurrent topics in Atulya Aman Khosla's work include Glioma Diagnosis and Treatment (8 papers), Lung Cancer Research Studies (8 papers) and Brain Metastases and Treatment (7 papers). Atulya Aman Khosla is often cited by papers focused on Glioma Diagnosis and Treatment (8 papers), Lung Cancer Research Studies (8 papers) and Brain Metastases and Treatment (7 papers). Atulya Aman Khosla collaborates with scholars based in United States, India and Ecuador. Atulya Aman Khosla's co-authors include Manmeet S. Ahluwalia, Rupesh Kotecha, Yazmín Odia, Ahmad Ozair, Michael McDermott, Rohit Singh, David M. Peereboom, Reid S. Alisch, Michael W. McDermott and Aakash Desai and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Atulya Aman Khosla

39 papers receiving 217 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Atulya Aman Khosla United States 8 74 70 61 60 31 52 221
Diana Isabel Rosero Spain 7 57 0.8× 51 0.7× 101 1.7× 47 0.8× 42 1.4× 11 205
Angelo Dipasquale Italy 9 36 0.5× 80 1.1× 66 1.1× 55 0.9× 25 0.8× 23 217
Julian Philipp Layer Germany 8 42 0.6× 41 0.6× 81 1.3× 54 0.9× 44 1.4× 30 218
Kaleigh Fetcko United States 6 67 0.9× 86 1.2× 100 1.6× 47 0.8× 104 3.4× 9 273
S. Grisanti Italy 8 31 0.4× 34 0.5× 72 1.2× 35 0.6× 17 0.5× 21 213
Charissa Jessurun Netherlands 6 57 0.8× 49 0.7× 92 1.5× 33 0.6× 35 1.1× 11 169
Vadim Tsvankin United States 8 96 1.3× 128 1.8× 107 1.8× 47 0.8× 136 4.4× 13 337
Rosemary Millen Australia 9 29 0.4× 24 0.3× 85 1.4× 48 0.8× 24 0.8× 15 168
Andrea Plaja Spain 5 21 0.3× 52 0.7× 41 0.7× 75 1.3× 28 0.9× 11 170
Wei-Chi Wu Taiwan 9 25 0.3× 45 0.6× 26 0.4× 71 1.2× 71 2.3× 31 260

Countries citing papers authored by Atulya Aman Khosla

Since Specialization
Citations

This map shows the geographic impact of Atulya Aman Khosla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atulya Aman Khosla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atulya Aman Khosla more than expected).

Fields of papers citing papers by Atulya Aman Khosla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atulya Aman Khosla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atulya Aman Khosla. The network helps show where Atulya Aman Khosla may publish in the future.

Co-authorship network of co-authors of Atulya Aman Khosla

This figure shows the co-authorship network connecting the top 25 collaborators of Atulya Aman Khosla. A scholar is included among the top collaborators of Atulya Aman Khosla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atulya Aman Khosla. Atulya Aman Khosla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rubens, Muni, Venkataraghavan Ramamoorthy, Anshul Saxena, et al.. (2025). Trends and outcomes of heart failure hospitalizations during COVID-19 pandemic. BMC Public Health. 25(1). 864–864. 1 indexed citations
2.
Khosla, Atulya Aman, et al.. (2025). Exploring trends in Medicare utilization and reimbursement of germline genetic testing for cancer from 2017-2022.. JCO Oncology Practice. 21(10_suppl). 5–5.
3.
Khosla, Atulya Aman, et al.. (2024). Measured Steps: Navigating the Path of Oligoprogressive Lung Cancer with Targeted and Immunotherapies. Current Oncology Reports. 26(1). 80–89.
4.
Khosla, Atulya Aman, Khurram Nasir, Anshul Saxena, et al.. (2024). Association between high risk of obstructive sleep apnea and inflammatory markers in a population sample of young and middle-aged adults in the Miami Heart Study. Journal of Clinical Sleep Medicine. 20(12). 1895–1903. 1 indexed citations
5.
Ahluwalia, Manmeet S., Michael J. Ciesielski, David A. Reardon, et al.. (2024). A multicenter, randomized controlled phase 2b trial of survivin vaccine SurVaxM plus adjuvant temozolomide for newly diagnosed glioblastoma (SURVIVE).. Journal of Clinical Oncology. 42(16_suppl). TPS2099–TPS2099. 4 indexed citations
6.
7.
Singh, Rohit, et al.. (2024). Talimogene laherparepvec (T-VEC) and Emerging Intralesional Immunotherapies for Metastatic Melanoma: A Review. Current Oncology Reports. 26(12). 1651–1663. 6 indexed citations
8.
Ahluwalia, Manmeet S., Atulya Aman Khosla, Ahmad Ozair, Mohamed A. Gouda, & Vivek Subbiah. (2024). Impact of tissue-agnostic approvals on management of primary brain tumors. Trends in cancer. 10(3). 256–274. 2 indexed citations
9.
Khosla, Atulya Aman, et al.. (2024). YouTube as a reliable source of information on antibody drug conjugates: A qualitative analysis.. Journal of Clinical Oncology. 42(16_suppl). 9050–9050. 1 indexed citations
10.
Khosla, Atulya Aman, et al.. (2024). P3.13D.01 Proteomic Characterization of Antibody Drug Conjugate Target Expression Profiles in Small Cell Lung Cancer (SCLC). Journal of Thoracic Oncology. 19(10). S359–S359. 1 indexed citations
11.
Appunni, Sandeep, Yanjia Zhang, Atulya Aman Khosla, et al.. (2024). Sex disparities in outcomes among hospitalizations for heart failure. Scientific Reports. 14(1). 27054–27054. 1 indexed citations
12.
Khosla, Atulya Aman, et al.. (2023). The Utility of Bronchoscopy in Hydralazine-Induced ANCA-Associated Vasculitis. SHILAP Revista de lepidopterología. 2023. 1–4.
13.
OʼShea, Patrick, Ahmad Ozair, Atulya Aman Khosla, et al.. (2023). First- versus Third-Generation EGFR Tyrosine Kinase Inhibitors in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Brain Metastases. Cancers. 15(8). 2382–2382. 10 indexed citations
14.
Chan, Kelvin, Atulya Aman Khosla, Muni Rubens, et al.. (2023). Prevalence and effects of acute myocardial infarction on hospital outcomes among COVID-19 patients. Coronary Artery Disease. 35(1). 38–43. 2 indexed citations
15.
Singh, Rohit, et al.. (2023). Racial Disparity in Hematopoietic Stem Cell Transplant Clinical Trial Recruitment. Blood. 142(Supplement 1). 3694–3694. 1 indexed citations
16.
Ahluwalia, Manmeet S., Michael McDermott, Terry C. Burns, et al.. (2023). Low-intensity focused ultrasound with systemic microbubble oscillators for blood-brain barrier disruption for liquid biopsy in glioblastoma (LIBERATE).. Journal of Clinical Oncology. 41(16_suppl). TPS2084–TPS2084. 1 indexed citations
17.
Khosla, Atulya Aman, et al.. (2023). Management of Brain Metastases: A Review of Novel Therapies. Seminars in Neurology. 43(6). 845–858. 5 indexed citations
18.
Ahluwalia, Manmeet S., Michael McDermott, Ahmad Ozair, et al.. (2023). RTID-01. A RANDOMIZED STUDY OF LOW-INTENSITY FOCUSED ULTRASOUND FOR BLOOD-BRAIN BARRIER DISRUPTION FOR BRAIN METASTASIS FROM NON-SMALL CELL LUNG CANCER (LIMITLESS). Neuro-Oncology. 25(Supplement_5). v258–v258.
19.
Ozair, Ahmad, Reid S. Alisch, Atulya Aman Khosla, et al.. (2023). DNA Methylation and Histone Modification in Low-Grade Gliomas: Current Understanding and Potential Clinical Targets. Cancers. 15(4). 1342–1342. 22 indexed citations
20.
Ahluwalia, Manmeet S., Michael McDermott, Atulya Aman Khosla, et al.. (2022). CTNI-10. RANDOMIZED PIVOTAL STUDY OF BLOOD-BRAIN BARRIER (BBB) DISRUPTION USING EXABLATE MODEL 4000 WITH STANDARD OF CARE (SOC) THERAPY IN NON-SMALL CELL LUNG CANCER (NSCLC) BRAIN METASTASES: LIMITLESS TRIAL. Neuro-Oncology. 24(Supplement_7). vii72–vii72. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Diana Isabel Rosero Breakdown of academic impact, for papers by Angelo Dipasquale Breakdown of academic impact, for papers by Julian Philipp Layer Breakdown of academic impact, for papers by Kaleigh Fetcko Breakdown of academic impact, for papers by S. Grisanti Breakdown of academic impact, for papers by Charissa Jessurun Breakdown of academic impact, for papers by Vadim Tsvankin Breakdown of academic impact, for papers by Rosemary Millen Breakdown of academic impact, for papers by Andrea Plaja Breakdown of academic impact, for papers by Wei-Chi Wu
Rankless by CCL
2026